The translation of scientific discoveries to clinical practice is rapidly rising on the list of research priorities, as stakeholders adjust to changing realities regarding:

  • The levels and sources of funding for biomedical research
  • Increasing sponsor expectations for clinically relevant and commercially viable research results
  • Growing recognition that pressing biomedical problems have a better chance of being solved in research environments with contributors from multiple disciplines

Massachusetts General Hospital is ideally positioned to contribute to and benefit from this burgeoning emphasis on translational research. Its mission—to excel in clinical medicine and scientific research, and to lead in training for both—contains the essential ingredients for successful translational research initiatives that will improve patient care.

The Strategic Alliances initiative is a cornerstone of the Mass General Research Institute’s mission to help scientists engage in more productive and long-lasting collaborations with industry at all stages of their work: from fundamental research to proof of concept, development, and transfer to market and patient care.

The three pillars of the Strategic Alliances initiative are:

  • Developing a comprehensive research portfolio to connect our investigators with industry partners
  • Creating cross-departmental, problem-driven research programs. This new approach combines intra-institutional collaborative structures with outreach approaches that extend the collaborative model to commercial partners. It leverages our high quality fundamental and translational research with our world class clinical care and patient-derived resources. It also provides opportunities for early business development input.
  • Launching a joint academia-industry translational research training program to develop future academic leaders that can work not only across multi-disciplinary scientific domains, but also understand the scientific and business principles that underlie translational research and move innovation to patient care

For more information about the Strategic Alliance initiative, please contact:

Gabriela Apiou, PhD
Director, Strategic Alliances
Mass General Research Institute
Contact by email | See Dr. Apiou's profile


Translational Research Training Program

The Massachusetts General Hospital Research Institute is launching Bridging Academia with Industry, a novel translational research training program.

The program is open to postdoctoral researchers and early career faculty from Mass General and other academic institutions, as well as industry scientists. It is designed and taught jointly by academic and industry faculty to provide participants with the understanding, methods and tools required to perform translational research and turn discoveries into new cures and diagnostics.

The first pillar is a course in translational research strategy and tactics providing:

  • Fundamentals of translational research, fields of investigation and process
  • Methods of research and development planning
  • Principles of intellectual property conception and protection
  • Basics of business development and commercialization Academia and industry perspectives are illustrated at each stage.

The second pillar is a translational research project, which provides one collaborative team with hands-on experience performing clinically relevant, problem-driven research while developing a go-to-market plan including intellectual property strategy, market analysis, regulatory strategy and economic assessment. The project will be chosen from proposals submitted by course participants, and the team will receive support and guidance from program faculty.

Back to Top